<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53587">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01823731</url>
  </required_header>
  <id_info>
    <org_study_id>NCCNCS-13-700</org_study_id>
    <nct_id>NCT01823731</nct_id>
  </id_info>
  <brief_title>A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <authority>Institutional Review Board in National Cancer Center :Korea</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      objectives: To development of NCC-PCI-Operative Template (NPOT) for the objective
      description of perioperative tumor burden and surgical approaches in the management of
      ovarian cancer, tubal cancer, and primary peritoneal cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Informed consent

        -  Digital photography &amp; Checking PCI (tumor size&amp; location )

        -  Postoperative surveillance(tumor marker, image and physical examination)

        -  Developing the best fitting NCC-PCI template to reflect recurrence and survival pattern
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>evaluation of Clinical Applicability about Synoptic Operative Template for Ovarian Cancer (SOTOC)</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Ovarian Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  ovarian cancer, tubal cancer, primary peritoneal cancer, mesothelioma, pseudomyxoma
             peritonei

          -  Debulking operation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preoperative clinical diagnosis of ovarian cancer, tubal cancer, and primary
             peritoneal carcinoma

          -  Available preoperative image study (CT and/or MRI and/or PET)

          -  Patients who gave a written informed consent

          -  Patients must be surgical candidate considering medical and psychological condition

        Exclusion Criteria:

          -  Patients who refuse to participate or want to withdraw at anytime.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 4, 2013</lastchanged_date>
  <firstreceived_date>March 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Sang-Yoon Park</investigator_full_name>
    <investigator_title>Chief, Center for Uterine Cancer</investigator_title>
  </responsible_party>
  <keyword>PCI,SOTOC, Ovarian cancer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
